Tidal Investments LLC Has $7.76 Million Holdings in Stryker Co. (NYSE:SYK)

Tidal Investments LLC increased its stake in shares of Stryker Co. (NYSE:SYK) by 23.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 21,551 shares of the medical technology company’s stock after purchasing an additional 4,073 shares during the quarter. Tidal Investments LLC’s holdings in Stryker were worth $7,759,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Stryker during the fourth quarter worth approximately $25,000. Rakuten Securities Inc. boosted its holdings in shares of Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company’s stock worth $28,000 after purchasing an additional 68 shares during the period. Centricity Wealth Management LLC acquired a new stake in shares of Stryker during the fourth quarter worth approximately $30,000. BankPlus Trust Department acquired a new stake in shares of Stryker during the fourth quarter worth approximately $33,000. Finally, VSM Wealth Advisory LLC acquired a new stake in shares of Stryker during the fourth quarter worth approximately $36,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Evercore ISI decreased their price target on shares of Stryker from $400.00 to $390.00 and set an “outperform” rating for the company in a report on Friday, May 2nd. Citigroup reaffirmed a “buy” rating and set a $450.00 price objective on shares of Stryker in a research report on Wednesday, February 26th. Barclays raised their price objective on shares of Stryker from $418.00 to $443.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. JPMorgan Chase & Co. raised their price objective on shares of Stryker from $420.00 to $445.00 and gave the company an “overweight” rating in a research report on Wednesday, January 29th. Finally, Canaccord Genuity Group raised their price objective on shares of Stryker from $420.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.05.

Stryker Trading Up 0.1%

NYSE:SYK opened at $394.63 on Tuesday. Stryker Co. has a 12 month low of $314.93 and a 12 month high of $406.19. The firm has a market cap of $150.63 billion, a price-to-earnings ratio of 50.85, a P/E/G ratio of 2.93 and a beta of 0.93. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The company’s 50 day moving average is $367.24 and its 200-day moving average is $375.80.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.73 by $0.11. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The business had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. During the same quarter in the previous year, the firm posted $2.50 earnings per share. Stryker’s revenue was up 11.9% compared to the same quarter last year. Equities analysts anticipate that Stryker Co. will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend is Monday, June 30th. Stryker’s dividend payout ratio (DPR) is currently 45.41%.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the business’s stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director now owns 3,417,326 shares of the company’s stock, valued at $1,288,195,208.96. The trade was a 5.53% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 5.90% of the stock is currently owned by insiders.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.